Insights

Loading spinner
Gathering insights about Avicanna Inc. (TSX:AVCN)

Similar companies to Avicanna Inc. (TSX:AVCN)

Avicanna Inc. (TSX:AVCN) Tech Stack

Avicanna Inc. (TSX:AVCN) uses 8 technology products and services including Google Workspace, jQuery Migrate, Google Tag Manager, and more. Explore Avicanna Inc. (TSX:AVCN)'s tech stack below.

  • Google Workspace
    Email
  • jQuery Migrate
    Javascript Libraries
  • Google Tag Manager
    Tag Management
  • Bootstrap
    UI Frameworks
  • Vimeo
    Video Players
  • GoDaddy
    Web Hosting
  • Apache
    Web Servers
  • CSS
    Web Tools And Plugins

Media & News

Avicanna Inc. (TSX:AVCN)'s Email Address Formats

Avicanna Inc. (TSX:AVCN) uses at least 1 format(s):
Avicanna Inc. (TSX:AVCN) Email FormatsExamplePercentage
First.Last@avicanna.comJohn.Doe@avicanna.com
87%
First.Middle@avicanna.comJohn.Michael@avicanna.com
10%
FirstMiddle.Last@avicanna.comJohnMichael.Doe@avicanna.com
2%
FL@avicanna.comJD@avicanna.com
1%

Frequently Asked Questions

Where is Avicanna Inc. (TSX:AVCN)'s headquarters located?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)'s main headquarters is located at 661 University Avenue 1300 Toronto, Ontario m5g 0b7 Canada. The company has employees across 4 continents, including North AmericaSouth AmericaEurope.

What is Avicanna Inc. (TSX:AVCN)'s official website and social media links?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)'s official website is avicanna.com and has social profiles on LinkedInCrunchbase.

What is Avicanna Inc. (TSX:AVCN)'s SIC code NAICS code?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Avicanna Inc. (TSX:AVCN) have currently?

Minus sign iconPlus sign icon
As of May 2026, Avicanna Inc. (TSX:AVCN) has approximately 75 employees across 4 continents, including North AmericaSouth AmericaEurope. Key team members include Chief Executive Officer: A. A.Vice President - Operations: T. W.Vice President Commercial Operations Europe / Latam: J. K.. Explore Avicanna Inc. (TSX:AVCN)'s employee directory with LeadIQ.

What industry does Avicanna Inc. (TSX:AVCN) belong to?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN) operates in the Biotechnology Research industry.

What technology does Avicanna Inc. (TSX:AVCN) use?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)'s tech stack includes Google WorkspacejQuery MigrateGoogle Tag ManagerBootstrapVimeoGoDaddyApacheCSS.

What is Avicanna Inc. (TSX:AVCN)'s email format?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)'s email format typically follows the pattern of First.Last@avicanna.com. Find more Avicanna Inc. (TSX:AVCN) email formats with LeadIQ.

When was Avicanna Inc. (TSX:AVCN) founded?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN) was founded in 2016.

Avicanna Inc. (TSX:AVCN)

Biotechnology ResearchOntario, Canada51-200 Employees

Avicanna is a life sciences company focused on advancement and commercialization of evidence-based cannabinoid products for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform including R&D & clinical development that has led to the commercialization of 30+ products across various market segments: 

•	Medical Cannabis & Wellness Products (RHO Phyto™): The formulary offers a diverse range of proprietary formulations including oral, sublingual, topical, & transdermal deliveries with varying ratios of cannabinoids and is supported with ongoing patient, and medical community education. RHO Phyto is a leading medical brand in Canada and is currently available nationwide to patients across several medical channels and continues to expand into new international markets.

•	Pharmaceutical Preparations and Pipeline: Leveraging Avicanna’s scientific platform, vertical integration, and real-world evidence, Avicanna has an extensive pipeline of indication-specific, patent-pending drug candidates in various stages of clinical development and commercialization. These drug candidates aim to address unmet medical needs in dermatology, chronic pain, and various neurological disorders. Avicanna’s first pharmaceutical preparation (Trunerox™) is approved in Colombia and is in registration in other South American markets.

•	MyMedi.ca Medical Cannabis Care: MyMedi.ca is a medical cannabis care platform formed with the aim to better serve medical cannabis patients’ needs and enhance the patient journey. MyMedi.ca is operated by Northern Green Canada Inc., and features a diverse portfolio of products and pharmacist-led patient support programs. It also provides specialty services to distinct patient groups such as veterans and collaborates with public and private providers for adjudication and reimbursement. MyMedi.ca provides educational resources to facilitate the incorporation of medical cannabis into health care regimens.

Section iconCompany Overview

Headquarters
661 University Avenue 1300 Toronto, Ontario m5g 0b7 Canada
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $1M$10M

    Avicanna Inc. (TSX:AVCN)'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Avicanna Inc. (TSX:AVCN)'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.